INTRODUCTION {#sec1-1}
============

Periodontitis is an inflammatory disease of the supporting tissues of teeth caused by specific microorganisms or group of specific microorganisms resulting in progressive destruction of the periodontal ligament and alveolar bone with pocket formation, recession, or both.\[[@ref1]\] The rationale of periodontal therapy is not only to control inflammation but also to reduce periodontal pockets and regeneration of alveolar bone, cementum, and periodontal attachment.\[[@ref2][@ref3]\] Autogenous grafts are considered to be the gold standard among graft materials\[[@ref4]\] because they are superior at retaining cell viability, contain osteoblasts and osteoprogenitor stem cells and heal by osteogenesis, avoid the potential problems of histocompatibility differences and risk of disease transfer.\[[@ref5]\] Allografts, such as DFDBA, exposes the bone inductive proteins located in the bone matrix such as bone morphogenetic protein-2 (BMP2) and BMP7,\[[@ref6]\] which are capable of inducing mesenchymal cells to differentiate into osteoblasts *in vivo*.\[[@ref7][@ref8]\] The ultimate goal of periodontal therapy is the regeneration of alveolar bone, cementum, and periodontal ligament. Therefore, the shift in therapeutic concepts from conventional therapy to regeneration has significantly impacted the practice of periodontology with greater efforts being directed towards the establishment of a new attachment apparatus in intrabony defects.\[[@ref9]\] The aim of the present study was to compare and evaluate clinically, as well as radiographically, the efficacy of Mineralized Cancellous Bone Allograft (Puros^®^) and Autogenous Bone in human periodontal intra osseous defects over 6 months period.

MATERIALS AND METHODS {#sec1-2}
=====================

Ten patients with 12 intrabony defect sites who attended the outpatient Department of Ragas Dental College and Hospital, Chennai were included in the study. Patients were randomly assigned to two study groups, i.e., A and B. Patients within the age group of 35--50 years diagnosed with generalized chronic periodontitis exhibiting multiple intrabony defects (two wall and three wall defects), probing depth of \>5 mm, sufficient keratinized tissue to allow complete tissue coverage of the defect, a radiographic evidence of vertical osseous defect with base at least 3 mm coronal to the apex of tooth, and patients who had not undergone any type of periodontal therapy in the past 6 months were included in the study. Patients with any systemic conditions which would compromise the outcome of periodontal therapy, pregnant or lactating women, teeth exhibiting mobility, patients known to be allergic to antibiotics/drugs, smokers and patients who were unable to maintain periodic recall visits were excluded from study.

Once the patients were included into the study, the entire study protocol was explained in detail to the patient, after which a consent form was signed. The study was approved by the Institutional Review Board of Ragas Dental College and Hospital. Initial therapy scaling and root planing were performed in a two sessions. Plaque control was assessed at the end of each scaling and root planing session and oral hygiene instructions were reinforced. After completion of the initial therapy, a re-evaluation was done after 4--6 weeks. At this point, periodontal charting was repeated to assess the response to initial therapy and to review the criteria for surgery with respect to probing depth and attachment levels. The patients were randomly allocated into groups A and B by tossing a coin.

Group A -- Patients treated with mineralized cancellous bone allograft (Puros^®^).

Group B -- Patients treated with autogenous bone.

Radiographic assessment {#sec2-1}
-----------------------

The following parameters were recorded:

A -- Cementoenamel junction (CEJ) to the most coronal point of the alveolar crest (AC).

B -- Cementoenamel junction (CEJ) to most apical point of the base of the defect (BD).

The parameters were denoted at

Baseline as A~0~ B~0~

1 month A~1~ B~1~

3 months A~3~ B~3~

Six months A~6~ B~6~.

Defect depth {#sec2-2}
------------

Defect depth (DD) was measured as the distance from the alveolar crest to the base of the osseous defect, at baseline 1, 3, and 6 months using the formula.\[[@ref10][@ref11]\]

DD = (CEJ to BD) − (CEJ to AC)

Defect fill percentage at six months: B~0~ − B~6~/B~0~ × 100

Defect resolution percentage at six months:

(B~0~ − A~0~) − (B~6~ − A~6~)/B~0~ − A~0~ × 100

Surgical protocol {#sec2-3}
-----------------

Surgical procedures were performed under local anesthesia, sulcular incisions were given and full thickness mucoperiosteal flaps were elevated, sites were thoroughly scaled, and root planed with both hand and ultrasonic instruments. All granulomatous tissue was removed. Out of 12 sites in the study groups, 6 were randomly treated with Puros^®^ \[[Figure 1](#F1){ref-type="fig"}\] and 6 were treated with autogenous bone scrapings. In group A, Puros^®^ was taken into a sterile dappen dish and mixed with saline \[[Figure 2](#F2){ref-type="fig"}\]. A moist gauze was used to remove any excess saline and the graft was placed into the defect. Small increments of the graft material were added and condensed into the defect till the defect was filled. In group B, the mucoperiosteal flap at the defect site and adjacent tooth was extended to expose the buccal shelf area. Ebner\'s grafter was used in pull motion to scrape graft from the exposed bone \[[Figure 3](#F3){ref-type="fig"}\]. The bone scrapings were collected into a sterile dappen dish, and the graft was placed in to the defect in increments and condensed till the defect was filled. Flaps were approximated and closed by using 4--0 black silk interrupted sutures. Periodontal dressing was given with COE-Pak^®^. Postoperative instructions were given.

![Mineralized cancellous bone allograft (Puros^®^)](JISPCD-6-248-g001){#F1}

![Puros taken in sterile dappen dish](JISPCD-6-248-g002){#F2}

![Ebner\'s grafter](JISPCD-6-248-g003){#F3}

After 1 week, sutures were removed, and if any plaque was found to be present at the surgical site, it was removed using moist gauze piece soaked in antiseptic solution. Follow up and plaque control was done on the 14^th^ and 30^th^ day, respectively. Periodic recall visits were scheduled at 1 month, 3 months, and 6 months time interval. At these visits, professional oral prophylaxis was done if necessary and oral hygiene reinforcements were implemented.

RESULTS {#sec1-3}
=======

Clinical parameters {#sec2-4}
-------------------

### Plaque index for group A (Puros^®^) {#sec3-1}

The mean plaque index scores at baseline was 1.35 ± 0.30, reduction in the mean plaque index score at 1 month was recorded as 0.89 ± 0.16, at 3 months 0.75 ± 0.00, and at 6 months was 0.67 ± 0.13. Comparing with the baseline value, changes in the mean plaque index scores at different time intervals with a *P* value of \<0.05 was statistically significant \[[Table 1](#T1){ref-type="table"}\].

###### 

Intergroup difference in the mean plaque index and gingival index scores between groups A and B

![](JISPCD-6-248-g004)

### Plaque index for group B (autogenous) {#sec3-2}

The mean plaque index score at baseline was 1.42 ± 0.35, reduction in the mean plaque index score at 1 month was recorded to be 0.85 ± 0.12, at 3 months 0.64 ± 0.12, and at 6 months was 0.59 ± 0.13. Comparing with the baseline value, changes in the mean plaque index scores at different time intervals with a *P* value of \<0.05 was statistically significant \[[Table 1](#T1){ref-type="table"}\].

Intergroup comparison of the changes in the mean plaque index scores between the groups at 1 month, 3 months, and 6 months time intervals had a *P* value was \>0.05, which was not statistically significant \[[Table 3](#T3){ref-type="table"}\].

### Gingival index for group A (Puros^®^) {#sec3-3}

The mean gingival index score at baseline was 1.25 ± 0.25, reduction in the mean gingival index score at 1 month was recorded to be 0.87 ± 0.12, at 3 months was 0.71 ± 0.10, and at 6 months was 0.58 ± 0.13. Comparing with the baseline value, changes in the mean gingival index scores at different time intervals with a *P* value of \<0.05 was statistically significant \[[Table 1](#T1){ref-type="table"}\].

### Gingival index for group B (autogenous) {#sec3-4}

The mean gingival index score at baseline was 1.28 ± 0.27, reduction in the mean gingival index score at 1 month was recorded to be 0.80 ± 0.27, at 3 months was 0.62 ± 0.13, and at 6 months was 0.58 ± 0.13. Comparing with the baseline value, changes in the mean gingival index scores at different time intervals with a *P* value \<0.05 was statistically significant \[[Table 1](#T1){ref-type="table"}\].

Intergroup comparison of the changes in the mean gingival index scores between the groups at 1 month, 3 months, and 6 months time intervals had a *P* value of \> 0.05, which was not statistically significant \[[Table 3](#T3){ref-type="table"}\].

### Probing pocket depth for group A (Puros^®^) {#sec3-5}

The mean probing pocket depth scores at baseline was 6.16 ± 1.47, which reduced to 2.33 ± 0.51 at the end of 1 month, 2.83 ± 0.98 at the end of 3 months, and 3.00 ± 0.89 at the end of 6 months. Comparing with the baseline value, the changes in the mean probing pocket depth scores at different time intervals with a *P* value of \<0.01 was statistically significant \[[Table 2](#T2){ref-type="table"}\].

###### 

Mean probing pocket depth and mean clinical attachment level at different time intervals in groups A and B

![](JISPCD-6-248-g005)

### Probing pocket depth for group B (autogenous) {#sec3-6}

The mean probing pocket depth score at baseline was 5.83 ± 0.40, which reduced to 2.50 ± 0.54 at the end of 1 month, 2.83 ± 0.75 at the end of 3 months, and 2.83 ± 0.75 at the end of 6 months. Comparing with the baseline value, the changes in the mean probing pocket depth scores at different time intervals with a *P* value of \<0.01 was statistically significant \[[Table 2](#T2){ref-type="table"}\].

Intergroup comparison of changes in the mean probing pocket depth scores between the groups at 1 month, 3 months, and 6 months time intervals had a *P* value of \>0.05, which was not statistically significant \[[Table 3](#T3){ref-type="table"}\].

###### 

Intergroup difference in the mean probing pocket depth and clinical attachment level

![](JISPCD-6-248-g006)

### Clinical attachment level for group A (Puros^®^) {#sec3-7}

The mean clinical attachment level score at baseline was 6.00 ± 1.78, the mean gain in clinical attachment level was 3.00 ± 0.63 at the end of 1 month, 3.33 ± 1.03 at the end of 3 months, and 3.33 ± 1.03 at the end of 6 months. Comparing with the baseline value, the changes in the mean clinical attachment level scores at different time intervals with a *P* value of \< 0.01 was statistically significant \[[Table 2](#T2){ref-type="table"}\].

### Clinical attachment level for group B (Autogenous) {#sec3-8}

The mean clinical attachment level score at baseline was 5.66 ± 1.21, the mean gain in clinical attachment level was 2.83 ± 0.75 at the end of 1 month, 3.00 ± 1.26 at the end of 3 months, and 3.00 ± 1.26 at the end of 6 months. Comparing with the baseline value, the changes in the mean clinical attachment level scores at different time intervals with a *P* value \<0.01 was statistically significant \[[Table 2](#T2){ref-type="table"}\].

Intergroup comparison of changes in the mean clinical attachment level scores between the groups at 1 months, 3 months, and 6 months time intervals had a *P* value of \>0.05, which was not statistically significant \[[Table 3](#T3){ref-type="table"}\].

Radiographic measurements: {#sec2-5}
--------------------------

### Defect depth for group A (Puros^®^) {#sec3-9}

The mean baseline CEJ-AC (A~0~) and CEJ-BD value is 7.27 ± 2.02 and 12.01 ± 2.52, respectively \[[Table 4](#T4){ref-type="table"}\]. The mean defect depth (DD) at the baseline was 4.77 ± 1.23 at 1 month it is 2.27 ± 0.83, at 3 month it is 1.32 ± 0.35, and at 6 months it was 0.92 ± 0.22. Comparing to the baseline value, the changes in the defect depth values at different time intervals with a *P* value ≤0.01 was statistically significant at 1% level \[[Table 5](#T5){ref-type="table"}\].

###### 

Mean value of alveolar crest (CEJ-AC) and base of defect (CEJ-BD) at the baseline in groups A and B

![](JISPCD-6-248-g007)

###### 

Mean defect depth (DD) at different time intervals in groups A and B

![](JISPCD-6-248-g008)

### Defect depth for group B (autogenous) {#sec3-10}

The mean baseline CEJ-AC (A~0~) and CEJ-BD value is 6.13 ± 1.28 and 10.99 ± 1.97, respectively \[[Table 4](#T4){ref-type="table"}\]. The mean defect depth (DD) at the baseline was 6.30 ± 2.35 at 1 month it is 3.82 ± 1.52, at 3 months it is 2.77 ± 1.51, and at 6 months it was 1.74 ± 1.30. Comparing to the baseline value, the changes in the defect depth values at different time intervals with a *P* value ≤0.01 was statistically significant at 1% level \[[Table 5](#T5){ref-type="table"}\].

Inter group comparison of changes in the mean defect depth values between the groups at 1 months, 3months and 6 months time intervals had a *P* value \>0.05, which was not statistically significant \[[Table 6](#T6){ref-type="table"}\].

###### 

Intergroup difference in the mean defect depth scores at different time intervals

![](JISPCD-6-248-g009)

Percentage of defect fill at six months {#sec2-6}
---------------------------------------

The mean percentage of defect fill for group A was 52 ± 12.49 and for group B it was 37.75 ± 11.99. The intergroup *P* value is \>0.05, which was not statistically significant \[[Table 7](#T7){ref-type="table"}\].

###### 

Intergroup mean percentage of defect fill and defect resolution at 6 months

![](JISPCD-6-248-g010)

Percentage of defect resolution at six months {#sec2-7}
---------------------------------------------

The mean percentage of defect resolution for group A was 49.28 ± 27.73 and for group B it was 65.82 ± 21.00. The intergroup *P* value was \>0.05, which was not statistically significant \[[Table 7](#T7){ref-type="table"}\].

DISCUSSION {#sec1-4}
==========

Puros^®^ (Zimmer Dental Inc., Carlsbad, CA) is an allogenic, solvent-preserved, human cancellous bone graft material. The donor bone was subjected to the Tutoplast^®^ Process which included delipidization, osmotic treatment, oxidative treatment, solvent dehydration, and sterilization through limited-dose gamma radiation.\[[@ref12][@ref13]\] This solvent-preserved allograft (as opposed to freeze drying to extract the water component) has been shown to osseointegrate as effectively as cryopreserved material and to be equally biocompatible. Animal and human studies of this material have shown good bone formation and repair.\[[@ref14]\] Autogenous bone has been considered to exhibit osteogenic, osteoinductive, and osteoconductive properties, and has thus, been used with the intent to improve outcomes of periodontal regenerative procedures.\[[@ref4][@ref15]\] In the present study, the selected sample sites in both the groups showed overall reduction in the mean probing pocket depth and marked gain in the clinical attachment level, which could be attributed to the resolution of tissue inflammation, reconstruction of the supporting periodontal structures in terms of alveolar bone, periodontal ligament in accordance with the previous studies.\[[@ref16]\] Meta-analysis performed by Reynolds *et al*. on 12 studies showed greater clinical attachment loss gain and a significantly greater probing depth reduction was reported for bone allograft treatment 0.43 mm (SD: 2.25) compared with open flap debridement (OFD).\[[@ref17][@ref18]\] The regeneration of the periodontal attachment apparatus in the present study had a favorable clinical and radiological outcome while using both bone replacement grafts mineralized cancellous bone allograft (Puros^®^) and autogenous bone.\[[@ref9]\] However, it is necessary to have a large sample size, greater duration of study, and assessment using surgical re-entry or advanced radiographical aids would provide more definitive information.

CONCLUSION {#sec1-5}
==========

Both mineralized cancellous bone allograft, Puros^®^ and autogenous bone has the potential to promote predictable periodontal regeneration in the treatment of periodontal intraosseous defects and showed significant improvement in all clinical and radiographical parameters at the end of six months. There was no statistically significant difference between group A and Group B.
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